# Efficacy of Adipose Derived Stromal Vascular Fraction in the Treatment of Keloids

> **NCT04391621** · PHASE2 · UNKNOWN · sponsor: **Makerere University** · enrollment: 30 (estimated)

## Conditions studied

- Adipose Derived Stem Cells
- Keloid

## Interventions

- **PROCEDURE:** Autologous Adipose Derived stem cell transplantation
- **DRUG:** Triamcinolone Acetonide 40Mg/Ml Inj,Susp_#1

## Key facts

- **NCT ID:** NCT04391621
- **Lead sponsor:** Makerere University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-05-01
- **Primary completion:** 2021-12-30
- **Final completion:** 2023-12-31
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2021-06-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04391621

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04391621, "Efficacy of Adipose Derived Stromal Vascular Fraction in the Treatment of Keloids". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT04391621. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*